{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:45:09Z","timestamp":1790390709581,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science, Technology & Innovation Funding Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nonalcoholic fatty liver disease (NAFLD) has been linked with a number of extra hepatic diseases and could be a potential risk factor of decreasing bone mineral density. To determine whether Upper Egyptian patients with NAFLD are at risk of developing osteoporosis. Cross sectional study was done on a total 100 individuals; 50 patients diagnosed with NAFLD (based on ultrasound imaging) crossed-matched with 50 individuals without NAFLD based on age, sex and body mass index. Bone mineral density, serum calcium and phosphorus levels, serum parathyroid hormone, serum vitamin D and fasting insulin level were assessed. Osteoporosis was prevalent in NAFLD patients versus to controls (19\/50 vs. 0\/50;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). There was significant decrease in bone mineral density in NAFLD patients than controls (\u2212\u20092.29\u2009\u00b1\u20090.4 vs. \u2212\u20091.53\u2009\u00b1\u20090.1;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). There was a statistical significance decrease in serum vitamin D and calcium levels in NAFLD patients than controls. Furthermore, vitamin D levels in the NAFLD group was a predictor for osteoporosis (OR 0.614; 95% CI 0.348\u20130.825). Patients with NAFLD tend to have a significant decrease in bone density, vitamin D, and serum calcium levels than controls.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-31256-w","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T19:02:28Z","timestamp":1678993348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-6757","authenticated-orcid":false,"given":"Amro M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ahmed","family":"Haridy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Z.","family":"Shoaeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Khairy","family":"Qura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eglal M.","family":"Kenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Mohamed M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Salaheldin Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Esmat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Mohamed","family":"Abdelmeguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-4715","authenticated-orcid":false,"given":"Muhammad","family":"Abdel-Gawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"31256_CR1","first-page":"4731","volume":"20","author":"A Federico","year":"2016","unstructured":"Federico, A., Dallio, M., Masarone, M., Persico, M. & Loguercio, C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction. Eur. Rev. Med. Pharmacol. Sci. 20, 4731\u20134741 (2016).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"31256_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajg.2014.05.002","volume":"15","author":"YM Alkassabany","year":"2014","unstructured":"Alkassabany, Y. M., Farghaly, A. G. & El-Ghitany, E. M. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: A hospital-based study in Alexandria, Egypt. Arab. J. Gastroenterol. 15, 76\u201381 (2014).","journal-title":"Arab. J. Gastroenterol."},{"key":"31256_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11901-016-0295-9","volume":"15","author":"LB VanWagner","year":"2016","unstructured":"VanWagner, L. B. & Rinella, M. E. Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr. Hepatol. Rep. 15, 75\u201385 (2016).","journal-title":"Curr. Hepatol. Rep."},{"key":"31256_CR4","doi-asserted-by":"crossref","unstructured":"Pan, B., Yan, J., Zhao, P., Liu, J., Fu, S. Relationship between nonalcoholic fatty liver disease and bone mineral density in type 2 diabetic patients. Int. J. Diabetes Dev. Ctries (2021).","DOI":"10.1007\/s13410-021-01022-7"},{"issue":"2","key":"31256_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5009\/gnl19069","volume":"14","author":"AA Li","year":"2020","unstructured":"Li, A. A., Ahmed, A. & Kim, D. Extrahepatic manifestations of nonalcoholic fatty liver disease. Gut Liver 14(2), 168\u2013178 (2020).","journal-title":"Gut Liver"},{"key":"31256_CR6","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-021-92703-0","volume":"11","author":"GE Chung","year":"2021","unstructured":"Chung, G. E. et al. Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea. Sci. Rep. 11, 13473 (2021).","journal-title":"Sci. Rep."},{"issue":"4","key":"31256_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut 71(4), 778\u2013788 (2022).","journal-title":"Gut"},{"issue":"10","key":"31256_CR8","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman, F. et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos. Int. 25(10), 2359\u20132381 (2014).","journal-title":"Osteoporos. Int."},{"issue":"1","key":"31256_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11657-014-0182-3","volume":"9","author":"SW Wade","year":"2014","unstructured":"Wade, S. W., Strader, C., Fitzpatrick, L. A., Anthony, M. S. & O\u2019Malley, C. D. Estimating prevalence of osteoporosis: Examples from industrialized countries. Arch Osteoporos. 9(1), 182 (2014).","journal-title":"Arch Osteoporos."},{"key":"31256_CR10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2147\/CIA.S170533","volume":"13","author":"R Filip","year":"2018","unstructured":"Filip, R., Radzki, R. P. & Bie\u0144ko, M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin. Interv. Aging 13, 1879\u20131891 (2018).","journal-title":"Clin. Interv. Aging"},{"key":"31256_CR11","first-page":"1","volume":"5","author":"K Premkumar","year":"2017","unstructured":"Premkumar, K. et al. Bone mineral density assessment in chronic liver disease. Arch Can. Res. 5, 1 (2017).","journal-title":"Arch Can. Res."},{"key":"31256_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/liv.13730","volume":"38","author":"N Guanabens","year":"2017","unstructured":"Guanabens, N. & Pares, A. Osteoporosis in chronic liver disease. Liver Int. 38, 776\u2013785 (2017).","journal-title":"Liver Int."},{"key":"31256_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/hep.21852","volume":"46","author":"J Collier","year":"2007","unstructured":"Collier, J. Bone disorders in chronic liver disease. Hepatology 46, 1271\u20131278 (2007).","journal-title":"Hepatology"},{"key":"31256_CR14","doi-asserted-by":"publisher","first-page":"825448","DOI":"10.3389\/fendo.2021.825448","volume":"12","author":"T Zhai","year":"2022","unstructured":"Zhai, T., Chen, Q., Xu, J., Jia, X. & Xia, P. Prevalence and trends in low bone density, osteopenia and osteoporosis in U.S. adults with non-alcoholic fatty liver disease, 2005\u20132014. Front. Endocrinol. 12, 825448 (2022).","journal-title":"Front. Endocrinol."},{"key":"31256_CR15","doi-asserted-by":"crossref","unstructured":"Cui, R., Sheng, H., Rui, X. F., Cheng, X. Y., Sheng, C. J., Wang, J. Y., et al. Low bone mineral density in Chinese adults with nonalcoholic fatty liver disease. Int. J. Endocrinol. 396545 (2013).","DOI":"10.1155\/2013\/396545"},{"key":"31256_CR16","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li, M. et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J. Clin. Endocrinol. Metab. 97, 2033\u20132038 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"31256_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s40618-016-0528-3","volume":"39","author":"SH Lee","year":"2012","unstructured":"Lee, S. H. et al. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults. J. Endocrinol. Invest. 39(11), 1329\u20131336 (2012).","journal-title":"J. Endocrinol. Invest."},{"issue":"11","key":"31256_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4254\/wjh.v5.i11.627","volume":"5","author":"M Kaya","year":"2013","unstructured":"Kaya, M. et al. Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J. Hepatol. 5(11), 627\u2013634 (2013).","journal-title":"World J. Hepatol."},{"key":"31256_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","volume":"38","author":"G Targher","year":"2015","unstructured":"Targher, G., Lonardo, A. & Rossini, M. nonalcoholic fatty liver disease and decreased bone mineral density: Is there a link?. J. Endocrinol. Invest. 38, 817\u2013825 (2015).","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"31256_CR20","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa, R., Lee, S., Chen, H. & Quon, M. J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol.-Endocrinol. Metab. 294(1), E15\u2013E26 (2008).","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"8","key":"31256_CR21","doi-asserted-by":"publisher","first-page":"190914","DOI":"10.2337\/dc06-0438","volume":"29","author":"C Meyer","year":"2006","unstructured":"Meyer, C. et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8), 190914 (2006).","journal-title":"Diabetes Care"},{"key":"31256_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745\u2013750 (2002).","journal-title":"Gastroenterology"},{"key":"31256_CR23","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjdrc-2019-000999","volume":"8","author":"X Zhu","year":"2020","unstructured":"Zhu, X. et al. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. BMJ Open Diabetes Res. Care 8, e000999 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"16","key":"31256_CR24","first-page":"1","volume":"7","author":"Y Uziel","year":"2020","unstructured":"Uziel, Y., Zifman, E. & Hashkes, P. J. Osteoporosis in children: pediatric and pediatric rheumatology perspective: A review. Pediatr. Rheumatol. 7(16), 1\u20138 (2020).","journal-title":"Pediatr. Rheumatol."},{"key":"31256_CR25","unstructured":"The International Society for Clinical Densitometry. ISCD official positions: Adult [Internet]. The International Society for Clinical Densitometry (2013)."},{"key":"31256_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00774-016-0807-2","volume":"35","author":"S Upala","year":"2017","unstructured":"Upala, S., Jaruvongvanich, V., Wijarnpreecha, K. & Sanguankeo, A. Nonalcoholic fatty liver disease and osteoporosis: A systematic review and metaanalysis. J. Bone Miner. Metab. 35, 685\u2013693 (2017).","journal-title":"J. Bone Miner. Metab."},{"key":"31256_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/apt.15087","volume":"49","author":"A Mantovani","year":"2019","unstructured":"Mantovani, A. et al. Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Aliment. Pharmacol. Ther. 49, 375\u2013388 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"31256_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/hep.30538","volume":"70","author":"A Mantovani","year":"2019","unstructured":"Mantovani, A. et al. Association between nonalcoholic fatty liver disease and reduced bone mineral density in children: a meta-analysis. Hepatology 70, 812\u2013823 (2019).","journal-title":"Hepatology"},{"key":"31256_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-016-0766-3","volume":"14","author":"MF Xia","year":"2016","unstructured":"Xia, M. F. et al. The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. J. Transl. Med. 14, 11. https:\/\/doi.org\/10.1186\/s12967-016-0766-3 (2016).","journal-title":"J. Transl. Med."},{"key":"31256_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/EJE-19-0699","volume":"182","author":"Z Shen","year":"2020","unstructured":"Shen, Z. et al. Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. Eur. J. Endocrinol. 182, 157\u2013164 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"31256_CR31","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00198-022-06459-y","volume":"33","author":"B Pan","year":"2022","unstructured":"Pan, B. et al. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Osteoporos. Int. 33, 2275\u20132286 (2022).","journal-title":"Osteoporos. Int."},{"issue":"08","key":"31256_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1055\/a-1482-9236","volume":"60","author":"SH Loosen","year":"2022","unstructured":"Loosen, S. H. et al. Non-alcoholic fatty liver disease is associated with increased incidence of osteoporosis and bone fracture. Z. Gastroenterol. 60(08), 1221\u20131227 (2022).","journal-title":"Z. Gastroenterol."},{"key":"31256_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2265.2011.04038.x","volume":"75","author":"O Pirgon","year":"2020","unstructured":"Pirgon, O., Bilgin, H., Tolu, I. & Odabas, D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin. Endocrinol. 75, 189\u2013195 (2020).","journal-title":"Clin. Endocrinol."},{"key":"31256_CR34","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1097\/MD.0000000000012835","volume":"97","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study. Medicine 97, e12835 (2018).","journal-title":"Medicine"},{"issue":"4","key":"31256_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22(4), 477\u2013501 (2001).","journal-title":"Endocr. Rev."},{"issue":"1","key":"31256_CR36","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.17554\/j.issn.2224-3992.2018.07.745","volume":"7","author":"MA Shawky","year":"2018","unstructured":"Shawky, M. A., Hassan, A. M., Mohammed, A. Q. & Oraby, M. I. Vitamin D levels in egyptian patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. Res. 7(1), 2530\u20132534 (2018).","journal-title":"J. Gastroenterol. Hepatol. Res."},{"key":"31256_CR37","first-page":"17221","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang, X., Li, W., Zhang, Y., Yang, Y. & Qin, G. Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: Results from a meta-analysis. Int. J. Clin. Exp. Med. 8, 17221\u201317234 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"31256_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.12377","volume":"38","author":"M Eliades","year":"2013","unstructured":"Eliades, M. et al. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 38(3), 246\u2013254 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"31256_CR39","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/jgh.12541","volume":"29","author":"LJ Black","year":"2014","unstructured":"Black, L. J. et al. Low serum 25-hydroxyvitamin D concentrations associate with nonalcoholic fatty liver disease in adolescents independent of adiposity. J. Gastroenterol. Hepatol. 29, 1215\u20131222 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"31256_CR40","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang, K. C. et al. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci. Rep. 6, 27034. https:\/\/doi.org\/10.1038\/srep27034 (2016).","journal-title":"Sci. Rep."},{"key":"31256_CR41","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini, M. et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5, 1544\u20131560 (2013).","journal-title":"Nutrients"},{"key":"31256_CR42","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jc.2013-3338","volume":"99","author":"D Shin","year":"2014","unstructured":"Shin, D., Kim, S., Kim, K. H., Lee, K. & Park, S. M. Association between insulin resistance and bone mass in men. J. Clin. Endocrinol. Metab. 99, 988\u2013995 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"31256_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bone.2015.07.027","volume":"82","author":"JN Farr","year":"2016","unstructured":"Farr, J. N. & Khosla, S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone 82, 28\u201334 (2016).","journal-title":"Bone"},{"issue":"3","key":"31256_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4239\/wjd.v2.i3.41","volume":"2","author":"K Wongdee","year":"2011","unstructured":"Wongdee, K. & Charoenphandhu, N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J. Diabetes 2(3), 41\u201348 (2011).","journal-title":"World J. Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31256-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31256-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31256-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T19:03:53Z","timestamp":1678993433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31256-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31256"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31256-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2106736\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4353"}}